Oncode Oncology Bridge Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 14

  • Portfolio
  • 7

  • Exits
  • 2

Exits

Oncode Oncology Bridge Fund General Information

Company Description

Founded in 2018, Oncode Oncology Bridge Fund is a venture capital fund based in Utrecht, Netherlands. The firm seeks to invest in early stage companies operating in the Oncology sector.

Business Details

Year Founded
2018
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • HI-FIVE 5th floor
  • Jaarbeursplein 6
  • 3521 AL Utrecht
  • Netherlands

Oncode Oncology Bridge Fund Investments (14)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Laigo Bio 20-Mar-2026 Seed Round Drug Discovery Generating Revenue
Cyclomics 07-Jan-2026 Biotechnology Generating Revenue
Flindr Therapeutics 28-Mar-2024 Drug Discovery Pre-Clinical Trials
Simmunext Biotherapeutics 09-Aug-2023 Biotechnology Startup
Cyclomics 03-Mar-2023 Biotechnology Generating Revenue
Single Cell Discoveries 01-May-2022 Other Pharmaceuticals and Biotechnology Generating Revenue
Laigo Bio 08-Feb-2022 Drug Discovery Generating Revenue
Simmunext Biotherapeutics 01-Jan-2022 Biotechnology Startup
Flindr Therapeutics 01-Nov-2021 Seed Round Drug Discovery Pre-Clinical Trials
Flindr Therapeutics 01-Sep-2020 Seed Round Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 14 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncode Oncology Bridge Fund Exits (2)

Company Name Exit Date Exit Type Exit Size
Cyclomics 01-Feb-2024 Merger/Acquisition
Single Cell Discoveries
To view Oncode Oncology Bridge Fund’s complete exits history, request access »

Oncode Oncology Bridge Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Oncode Oncology Bridge Fund Co-Investors (20)

Name With Exits Lead Partner Series Industry
Curie Capital 2 Series chart Industry bar
Cancer Research Technology Series chart Industry bar
Eurazeo Series chart Industry bar
Johnson & Johnson JJDC Series chart Industry bar
Kurma Partners Series chart Industry bar
You’re viewing 5 of 20 co-investors. Get the full list »

Oncode Oncology Bridge Fund FAQs

  • What is Oncode Oncology Bridge Fund?

    Founded in 2018, Oncode Oncology Bridge Fund is a venture capital fund based in Utrecht, Netherlands.

  • When was Oncode Oncology Bridge Fund founded?

    Oncode Oncology Bridge Fund was founded in 2018.

  • Where is Oncode Oncology Bridge Fund headquartered?

    Oncode Oncology Bridge Fund is headquartered in Utrecht, Netherlands.

  • How many investments has Oncode Oncology Bridge Fund made?

    Oncode Oncology Bridge Fund has made 14 investments.

  • What has Oncode Oncology Bridge Fund invested in?

    Oncode Oncology Bridge Fund has made numerous investments in companies like Laigo Bio, Cyclomics, and Flindr Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has Oncode Oncology Bridge Fund invested in recently?

    Oncode Oncology Bridge Fund's latest investment was on 20-Mar-2026 in Laigo Bio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process